Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Arvest Investments Inc.

Arvest Investments Inc. cut its stake in Molina Healthcare, Inc. (NYSE:MOH) by 2.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,958 shares of the company’s stock after selling 52 shares during the quarter. Arvest Investments Inc.’s holdings in Molina Healthcare were worth $804,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. McIlrath & Eck LLC purchased a new position in Molina Healthcare during the fourth quarter worth about $34,000. VisionPoint Advisory Group LLC increased its stake in Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares during the last quarter. Raleigh Capital Management Inc. raised its position in Molina Healthcare by 40.4% in the third quarter. Raleigh Capital Management Inc. now owns 125 shares of the company’s stock valued at $41,000 after purchasing an additional 36 shares during the period. Principal Securities Inc. acquired a new position in shares of Molina Healthcare in the 4th quarter valued at $42,000. Finally, Householder Group Estate & Retirement Specialist LLC grew its holdings in shares of Molina Healthcare by 3,933.3% during the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock worth $43,000 after purchasing an additional 118 shares during the period. Institutional investors and hedge funds own 98.50% of the company’s stock.

Insider Buying and Selling

In other Molina Healthcare news, COO James Woys sold 10,000 shares of Molina Healthcare stock in a transaction on Wednesday, May 22nd. The shares were sold at an average price of $345.15, for a total value of $3,451,500.00. Following the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at $18,504,526.95. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Molina Healthcare news, COO James Woys sold 10,000 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total value of $3,451,500.00. Following the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at approximately $18,504,526.95. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Ronna Romney sold 250 shares of the company’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total value of $85,817.50. Following the sale, the director now owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The disclosure for this sale can be found here. 1.11% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of research analysts have commented on MOH shares. Stephens reaffirmed an “equal weight” rating and issued a $390.00 target price on shares of Molina Healthcare in a research report on Thursday, April 25th. TD Cowen lowered their price objective on shares of Molina Healthcare from $453.00 to $412.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Bank of America lowered Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price on the stock. in a research report on Thursday, March 28th. Wells Fargo & Company lowered their price target on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating for the company in a research report on Monday, April 29th. Finally, Baird R W upgraded Molina Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Molina Healthcare has a consensus rating of “Moderate Buy” and an average price target of $407.45.

Molina Healthcare Stock Performance

Shares of Molina Healthcare stock opened at $296.10 on Thursday. The firm’s 50 day moving average is $323.97 and its two-hundred day moving average is $361.41. Molina Healthcare, Inc. has a 52 week low of $288.79 and a 52 week high of $423.92. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $17.35 billion, a P/E ratio of 16.07, a P/E/G ratio of 0.90 and a beta of 0.58.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. The business had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business’s revenue was up 21.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.81 earnings per share. Research analysts forecast that Molina Healthcare, Inc. will post 23.56 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.